ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
A Clinical Evaluation Of BW430C (Lamotrigine) In Bipolar I Disorder - Long-Term Extension Of Study SCA104779 -

This study is currently recruiting participants.
Study NCT00566020.   Last updated on November 19, 2008.   Information provided by GlaxoSmithKline
Please refer to this study by its ClinicalTrials.gov identifier: NCT00566020


Contacts
Contact: US GSK Clinical Trials Call Center     877-379-3718    

Locations
Japan
GSK Investigational Site     Completed
      Hokkaido, Japan, 060-8648
GSK Investigational Site     Recruiting
      Hokkaido, Japan, 060-0042
GSK Investigational Site     Not yet recruiting
      Fukuoka, Japan, 800-0217
GSK Investigational Site     Not yet recruiting
      Ibaraki, Japan, 311-3117
GSK Investigational Site     Not yet recruiting
      Kanagawa, Japan, 231-0023
GSK Investigational Site     Not yet recruiting
      Tokyo, Japan, 180-0005
GSK Investigational Site     Not yet recruiting
      Hiroshima, Japan, 737-0023
GSK Investigational Site     Not yet recruiting
      Fukuoka, Japan, 802-0001
GSK Investigational Site     Not yet recruiting
      Fukuoka, Japan, 802-0006
GSK Investigational Site     Not yet recruiting
      Fukuoka, Japan, 815-0041
GSK Investigational Site     Recruiting
      Aichi, Japan, 470-1141
GSK Investigational Site     Active, not recruiting
      Mie, Japan, 510-8575
GSK Investigational Site     Active, not recruiting
      Kyoto, Japan, 616-8421
GSK Investigational Site     Active, not recruiting
      Mie, Japan, 515-0044
GSK Investigational Site     Active, not recruiting
      Chiba, Japan, 289-2511
GSK Investigational Site     Active, not recruiting
      Chiba, Japan, 272-8516
GSK Investigational Site     Active, not recruiting
      Tokyo, Japan, 152-0012
GSK Investigational Site     Active, not recruiting
      Osaka, Japan, 590-0018
GSK Investigational Site     Active, not recruiting
      Kanagawa, Japan, 216-8511
GSK Investigational Site     Recruiting
      Kanagawa, Japan, 238-0042
GSK Investigational Site     Active, not recruiting
      Fukuoka, Japan, 810-0004
GSK Investigational Site     Active, not recruiting
      Tokyo, Japan, 113-8602
GSK Investigational Site     Active, not recruiting
      Fukuoka, Japan, 807-8555
GSK Investigational Site     Active, not recruiting
      Oita, Japan, 879-5593
GSK Investigational Site     Active, not recruiting
      Fukuoka, Japan, 830-0011
GSK Investigational Site     Active, not recruiting
      Oita, Japan, 874-0011
GSK Investigational Site     Active, not recruiting
      Hiroshima, Japan, 734-8551
GSK Investigational Site     Withdrawn
      Fukuoka, Japan, 812-8582
GSK Investigational Site     Withdrawn
      Aichi, Japan, 470-1168
GSK Investigational Site     Recruiting
      Kumamoto, Japan, 861-8002
GSK Investigational Site     Recruiting
      Hokkaido, Japan, 002-8029
GSK Investigational Site     Active, not recruiting
      Tottori, Japan, 682-0023
GSK Investigational Site     Not yet recruiting
      Tokyo, Japan, 187-8551
GSK Investigational Site     Withdrawn
      Kanagawa, Japan, 220-0004
GSK Investigational Site     Active, not recruiting
      Tokyo, Japan, 166-0003
GSK Investigational Site     Active, not recruiting
      Kanagawa, Japan, 225-0011
GSK Investigational Site     Active, not recruiting
      Tokyo, Japan, 151-0053
GSK Investigational Site     Active, not recruiting
      Yamagata, Japan, 999-2221
GSK Investigational Site     Active, not recruiting
      Osaka, Japan, 533-0005
GSK Investigational Site     Active, not recruiting
      Tokyo, Japan, 190-0023
GSK Investigational Site     Recruiting
      Chiba, Japan, 260-8677
GSK Investigational Site     Recruiting
      Gunma, Japan, 377-0055
GSK Investigational Site     Active, not recruiting
      Fukuoka, Japan, 814-0180
GSK Investigational Site     Active, not recruiting
      Osaka, Japan, 583-0884
GSK Investigational Site     Recruiting
      Tokyo, Japan, 170-0002
GSK Investigational Site     Active, not recruiting
      Oita, Japan, 879-7501
GSK Investigational Site     Not yet recruiting
      Osaka, Japan, 570-8507
GSK Investigational Site     Not yet recruiting
      Saga, Japan, 842-0192
GSK Investigational Site     Not yet recruiting
      Fukuoka, Japan, 812-8582
GSK Investigational Site     Not yet recruiting
      Kanagawa, Japan, 224-8503
GSK Investigational Site     Not yet recruiting
      Hokkaido, Japan, 064-0946
GSK Investigational Site     Not yet recruiting
      Tokyo, Japan, 154-0012
GSK Investigational Site     Not yet recruiting
      Kanagawa, Japan, 221-0835
GSK Investigational Site     Not yet recruiting
      Tottori, Japan, 680-0011
GSK Investigational Site     Recruiting
      Gunma, Japan, 375-0017
GSK Investigational Site     Not yet recruiting
      Nara, Japan, 634-8522
GSK Investigational Site     Withdrawn
      Kyoto, Japan, 602-8566
GSK Investigational Site     Recruiting
      Osaka, Japan, 569-1041
GSK Investigational Site     Not yet recruiting
      Tokyo, Japan, 173-0037
GSK Investigational Site     Active, not recruiting
      Tokyo, Japan, 183-0042
GSK Investigational Site     Active, not recruiting
      Saitama, Japan, 332-0012
GSK Investigational Site     Not yet recruiting
      Tokyo, Japan, 154-0004
GSK Investigational Site     Not yet recruiting
      Tokyo, Japan, 100-0006
GSK Investigational Site     Recruiting
      Okayama, Japan, 700-8558

Sponsors and Collaborators
GlaxoSmithKline

Investigators
Study Director:     GSK Clinical Trials, MD     GlaxoSmithKline    


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act
U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services



Links to all studies - primarily for crawlers